Background . Naringenin has shown great promise in the realm of cancer therapeutics, demonstrating excellent cytotoxic action toward cancer cells and the enhanced effects of radiation therapy in vitro . However, the medicinal value of naringenin is severely limited clinically by poor bioavailability. Thus, multiple drug‐delivery strategies for overcoming this limitation have been developed, of which liposomes are considered the most suitable due to their amphiphilic, modifiable, and biocompatible characteristics. In this study, we investigated the role of naringenin and liposomal‐delivered naringenin as adjuncts to radiotherapy in the MDA‐MB‐231 triple‐negative breast cancer cell line in vitro . Materials and Methods . Liposomal‐naringenin was synthesized by thin‐film hydration and extrusion and was characterized by spectrophotometry, dynamic light scattering, and zeta potential. The effects of free‐from naringenin and liposomal‐naringenin were evaluated toward MDA‐MB‐231 cell viability when combined with varying doses of radiation. Additionally, cell growth patterns, morphology, and colony formation were evaluated. Results . The analysis demonstrated IC 50 values of 387.5 and 546.6 µ g/ml for naringenin and liposomal‐naringenin, respectively. Naringenin and liposomal‐naringenin significantly lowered cell viability, proliferation, and colony formation dose‐dependently, as compared to radiation in isolation. Conclusion . The findings presented herein concur with previous accounts of the radiosensitizing potential of naringenin and further highlight the considerable biomedical application of liposomal‐naringenin within the realm of radiotherapy.
The emergence of SARS‐CoV‐2 and the subsequent COVID‐19 pandemic necessitated the development of adequate vaccines. Despite vaccines being demonstrated to be safe and effective for preventing severe disease and death, vaccine hesitancy remains. Reasons include concerns over adverse effects on male fertility, which have not been widely investigated. Therefore, this study is aimed at determining the impact of COVID‐19 vaccination on semen parameters in a retrospective cohort study of South African males undergoing fertility assessment. The patients for this study were adult men who have previously undergone routine semen analysis for fertility assessment at Androcryos Andrology Laboratory (Johannesburg, South Africa) between March 2021 and March 2022. They also received vaccination within 3 months following a semen analysis and underwent a second semen analysis any time post‐COVID‐19 vaccination. From 277 records analysed, 46 patients met the inclusion criteria, receiving the Pfizer‐BioNTech (BNT162b1) (63%), Johnson and Johnson (JNJ‐78436735/Ad26.COV2S) (34.8%), and the AstraZeneca (AZD1222) (2.2%) vaccines. Sperm concentration significantly increased postvaccination (P = 0.0001), with no significant changes in semen pH, volume, total sperm count, progressive motility, normal sperm morphology, or chromatin condensation. Results were not influenced by age, type of vaccine received, and the number of days following vaccination, as depicted by multiple regression analysis. In conclusion, there is no evidence of a negative impact of COVID‐19 vaccination on male semen parameters, which is consistent with the emerging literature on COVID‐19 vaccination and male fertility. COVID‐19 vaccinations should not be dismissed based on fear of adverse effects on male fertility parameters.
Bimetallic nanoparticles have garnered significant attention in scientific literature due to their diverse applications and unique properties. Concurrently, green synthesis methodologies have emerged as environmentally friendly alternatives, reducing the ecological footprint of nanoparticle production. In this study, the efficient synthesis of Au-Pd bimetallic nanoparticles is presented, utilizing Aspalathus linearis (Burm.f.) R. Dahlgren, commonly known as green rooibos (GR), and its pure bioactive compound, Aspalathin (ASP). Integrating ASP as a pure compound into the green synthesis process offers precise control over nanoparticle characteristics, including size, morphology, and composition. Interestingly, the total extract forms an Au-Pd nanoparticle alloy, while aspalathin forms core–shell nanoparticles. Furthermore, cytotoxicity testing was carried out on selected cell lines to assess their impact on cell viability. The cytotoxicity test on cell lines and cellular uptake analysis demonstrated that none of the tested samples exhibited significant cytotoxic effects. ASP-conjugated bimetallic increased the uptake of the NPs by the cells more than the total extract. The results demonstrated that the Au-Pd bimetallic nanoparticles hold promise for biomedical applications, owing to their enhanced biocompatibility and tailored properties.
16 September 2025 in South African Journal of Botany